Treatments in Endocrinology

, Volume 4, Issue 1, pp 55–64 | Cite as

Surgical Management of Obesity

A Review of Their Effects on Glucose Metabolism and Insulin Resistance
  • Michael D. Lara
  • Shanu N. Kothari
  • Harvey J. Sugerman
Review Article


Obesity continues to plague our society in epidemic proportions. Surgery for morbid obesity is considered by many as the most effective therapy for this complex disorder. Today, multiple surgical procedures for the treatment of obesity are available. As with most procedures, there are benefits and risks associated with open and laparoscopic gastric bypass surgery, as well as with laparoscopic adjustable gastric banding and partial biliopancreatic bypass with a duodenal switch. The risks and complications associated with bariatric surgery may be serious and in some cases life threatening. However, surgery for obesity has shown remarkable results in helping patients to achieve significant long-term weight control. In addition, it is associated with improvement and often resolution of co-morbid conditions, including type 2 diabetes mellitus, systemic hypertension, obesity hypoventilation, sleep apnea, venous stasis disease, pseudotumor cerebri, polycystic ovary syndrome, complications of pregnancy and delivery, gastroesophageal reflux disease, stress urinary incontinence, degenerative joint disease, and non-alcoholic steatohepatitis.


Obstructive Sleep Apnea Morbid Obesity Stress Urinary Incontinence Laparoscopic Adjustable Gastric Banding Duodenal Switch 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors gratefully acknowledge the assistance of Angela Kuhn in manuscript preparation. Dr Sugerman is on the Ethicon Endosurgery, Surgery Advisory Board and has been funded for speaking engagements by US Surgical Corporation. He is the President of the American Society for Bariatric Surgery and Editor in Chief of its new journal Surgery for Obesity and Related Diseases, both of which provide salary support. He is retired from the clinical practice of surgery. Dr Kothari receives fellowship support from US Surgical Corporation.


  1. 1.
    Martin LF, Tan TL, Horn JR, et al. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery 1995; 118: 599–606; discussion 606PubMedCrossRefGoogle Scholar
  2. 2.
    NIH. Gastrointestinal surgery for severe obesity: Consensus Development Conference Panel. Ann Intern Med 1991; 115: 956–61Google Scholar
  3. 3.
    Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, roux-en-Y: preliminary report of five cases. Obes Surg 1994; 4: 353–7PubMedCrossRefGoogle Scholar
  4. 4.
    Fredenheim M. Hospitals pressured by soaring demand for obesity surgery. New York Times 2003 Aug 29Google Scholar
  5. 5.
    Foley EF, Benotti PN, Borlase BC, et al. Impact of gastric restrictive surgery on hypertension in the morbidly obese. Am J Surg 1992; 163: 294–7PubMedCrossRefGoogle Scholar
  6. 6.
    Carson JL, Ruddy ME, Duff AE, et al. The effect of gastric bypass surgery on hypertension in morbidly obese patients. Ann Intern Med 1994; 154: 193–200CrossRefGoogle Scholar
  7. 7.
    Ben Dov I, Grossman E, Stein A, et al. Marked weight reduction lowers resting and exercise blood pressure in morbidly obese subjects. Am J Hypertens 2000; 13: 251–5CrossRefGoogle Scholar
  8. 8.
    Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237: 751–6PubMedGoogle Scholar
  9. 9.
    Sjostrom CD, Lissner L, Wedel H, et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999; 7: 477–84PubMedCrossRefGoogle Scholar
  10. 10.
    Sjostrom CD, Peltonen M, Sjostrom L. Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study. Obes Res 2001; 9: 188–95PubMedCrossRefGoogle Scholar
  11. 11.
    Cowan Jr GS, Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg 1998 Sep; 22(9): 987–92PubMedCrossRefGoogle Scholar
  12. 12.
    Gleysteen JJ. Results of surgery: long-term effects on hyperlipidemia. Am J Clin Nutr 1992; 55: 591S–3SPubMedGoogle Scholar
  13. 13.
    Brolin RE, Bradley LJ, Wilson AC, et al. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg 2000; 4: 464–9PubMedCrossRefGoogle Scholar
  14. 14.
    Buffington CK, Cowan Jr GS, Smith H. Significant changes in the lipid-lipoprotein status of premenopausal morbidly obese females following gastric bypass surgery. Obes Surg 1994; 4: 328–35PubMedCrossRefGoogle Scholar
  15. 15.
    Wolf AM, Beisiegel U, Kornter B, et al. Does gastric restriction surgery reduce the risks of metabolic diseases? Obes Surg 1998; 8: 9–13PubMedCrossRefGoogle Scholar
  16. 16.
    Busseto L, Pisent C, Rinaldi D, et al. Variation in lipid levels in morbidly obese patients operated with Lap-Band® adjustable gastric banding system: effects of different levels of weight loss. Obes Surg 2000; 10: 569–77CrossRefGoogle Scholar
  17. 17.
    Alpert MA, Terry BE, Kelly DL. Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol 1985; 55: 783–6PubMedCrossRefGoogle Scholar
  18. 18.
    Sugerman HJ, Baron PL, Fairman RP, et al. Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss. Ann Surg 1988; 207: 604–13PubMedCrossRefGoogle Scholar
  19. 19.
    Alaud-din A, Meterissian S, Lisbona R, et al. Assessment of cardiac function in patients who were morbidly obese. Surgery 1990; 108: 818–20Google Scholar
  20. 20.
    Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995 Sep; 222(3): 339–50PubMedCrossRefGoogle Scholar
  21. 21.
    MacDonald Jr KG, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997 May; 1(3): 213–20PubMedCrossRefGoogle Scholar
  22. 22.
    Dixon JB, O’Briend PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002; 25: 397–8CrossRefGoogle Scholar
  23. 23.
    Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467–84PubMedGoogle Scholar
  24. 24.
    Kellum J, Kuemmerle J, O’Darisio T, et al. Gastrointestinal hormone (GIH) responses to meals before and after gastric bypass and vertical banded gastro-plasty. Ann Surg 1990; 211: 763–70PubMedCrossRefGoogle Scholar
  25. 25.
    Hickey MS, Pories WJ, MacDonald Jr KG, et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 1998; 227: 637–43PubMedCrossRefGoogle Scholar
  26. 26.
    Clements RH, Gonzalez QH, Long CI, et al. Hormonal changes after Rouxen-Y gastric bypass for morbid obesity and the control of type II diabetes mellitus. Am Surg 2004; 70: 1–4PubMedGoogle Scholar
  27. 27.
    Sugerman HJ, Fairman RP, Baron PL, et al. Gastric surgery for respiratory insufficiency of obesity. Chest 1986 Jul; 90(1): 81–6PubMedCrossRefGoogle Scholar
  28. 28.
    Sugerman HJ, Fairman RP, Sood RK, et al. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr 1992; 55: 597 S–601 SGoogle Scholar
  29. 29.
    Charuzi I, Lavie P, Peiser J, et al. Bariatric surgery in morbidly obese sleep-apnea patients: short- and long-term follow-up. Am J Clin Nutr 1992 Feb; 55(2 Suppl.): 594S–6SPubMedGoogle Scholar
  30. 30.
    Peiser J, Ovnat A, Uwyyed K, et al. Cardiac arrhythmias during sleep in morbidly obese sleep-apneic patients before and after gastric bypass surgery. Clin Cardiol 1985 Oct; 8(10): 519–21PubMedCrossRefGoogle Scholar
  31. 31.
    Boone KA, Cullen JJ, Mason EE, et al. Impact of vertical banded gastroplasty on respiratory insufficiency of severe obesity. Obes Surg 1996; 6: 454–8PubMedCrossRefGoogle Scholar
  32. 32.
    Kyzer S, Charuzi I. Obstructive sleep apnea in the obese. World J Surg 1998; 22(9): 998–1001PubMedCrossRefGoogle Scholar
  33. 33.
    Rasheid S, Banasiak M, Gallagher SF, et al. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obes Surg 2003; 13: 58–61PubMedCrossRefGoogle Scholar
  34. 34.
    Deitel M, Stone E, Kassam HA, et al. Gynecologic-obstetric changes after loss of massive excess weight following bariatric surgery. J Am Coll Nutr 1988 Apr; 7(2): 147–53PubMedGoogle Scholar
  35. 35.
    Printen KJ, Scott D. Pregnancy following gastric bypass for the treatment of morbid obesity. Am Surg 1982 Aug; 48(8): 363–5PubMedGoogle Scholar
  36. 36.
    Rand CS, Macgregor AM. Medical care and pregnancy outcome after gastric bypass surgery for obesity. South Med J 1989 Oct; 82(10): 1319–20PubMedCrossRefGoogle Scholar
  37. 37.
    Friedman D, Cunco S, Valenzano M, et al. Pregnancies in an 18-year follow-up after biliopancreatic diversion. Obes Surg 1995; 5: 308–13PubMedCrossRefGoogle Scholar
  38. 38.
    Wittgrove AC, Jester L, Wittgrove P, et al. Pregnancy following gastric bypass for morbid obesity. Obes Surg 1998; 8: 461–4PubMedCrossRefGoogle Scholar
  39. 39.
    Dixon JB, Dixon ME, O’Brien PE. Pregnancy after Lap-Band® surgery: management of the band to achieve health weight outcomes. Obes Surg 2001; 11: 59–65PubMedCrossRefGoogle Scholar
  40. 40.
    Winiarsky R, Barth P, Lotke P. Total knee arthroplasty in morbidly obese patients. J Bone Joint Surg Am 1998 Dec; 80(12): 1770–4PubMedGoogle Scholar
  41. 41.
    Parvizi J, Trousadale RT, Sarr MG. Total joint arthroplasty in patients surgically treated for morbid obesity. J Arthroplasty 2000 Dec; 15(8): 1003–8PubMedCrossRefGoogle Scholar
  42. 42.
    Peltonen M, Lindroos AK, Torgerson JS. Musculoskeletal pain in the obese: a comparison with the general population and long-term changes after conventional and surgical obesity treatment. Pain 2003; 104: 549–57PubMedCrossRefGoogle Scholar
  43. 43.
    Bump RC, Sugerman HJ, Fantl JA, et al. Obesity and lower urinary tract function in women: effects of surgically induced weight loss. Am J Obstet Gynecol 1992; 167: 392–7PubMedGoogle Scholar
  44. 44.
    Sugerman HJ, Felton WL, Sismanis A, et al. Effects of surgically induced weight loss on pseudotumor cerebri in morbid obesity. Neurology 1995; 45: 1655–9PubMedCrossRefGoogle Scholar
  45. 45.
    Sugerman HJ, Felton III WL, Sismanis A, et al. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg 1999 May; 229(5): 634–40PubMedCrossRefGoogle Scholar
  46. 46.
    Smith SC, Edwards CB, Goodman GN. Symptomatic and clinical improvement in morbidly obese patients with gastroesophageal reflux disease following Rouxen-Y gastric bypass. Obes Surg 1997; 7: 479–84PubMedCrossRefGoogle Scholar
  47. 47.
    Frezza EE, Ikramuddin S, Gourash W, et al. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc 2002 Jul; 16(7): 1027–31PubMedCrossRefGoogle Scholar
  48. 48.
    Dixon JB, O’Brien PE. Gastroesophageal reflux in obesity: the effect of Lap-Band® placement. Obes Surg 1999; 9(6): 527–31PubMedCrossRefGoogle Scholar
  49. 49.
    Macgregor A, Greenberg RA. Effect of surgically induced weight loss on asthma in the morbidly obese. Obes Surg 1993; 3: 15–21PubMedCrossRefGoogle Scholar
  50. 50.
    Dixon JB, Chapman L, O’Brien P. Marked improvement in asthma after Lap-Band® surgery for morbid obesity. Obes Surg 1999; 9: 385–9PubMedCrossRefGoogle Scholar
  51. 51.
    Sugerman HJ, Kellum JM, DeMaria EJ. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg 2001; 234: 41–6PubMedCrossRefGoogle Scholar
  52. 52.
    Hui JM, Kench JG, Chitturi S, et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 2003; 38: 420–7PubMedCrossRefGoogle Scholar
  53. 53.
    Ranlov I, Hardt F. Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity. Digestion 1990; 47: 208–14PubMedCrossRefGoogle Scholar
  54. 54.
    Silverman EM, Sapala JA, Appelman HD. Regression of hepatic steatosis in morbidly obese persons after gastric bypass. Am J Clin Pathol 1995; 104: 23–31PubMedGoogle Scholar
  55. 55.
    Luyckx FH, Desaive C, Thiry A, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998; 22: 222–6PubMedCrossRefGoogle Scholar
  56. 56.
    Kral JG, Thung SN, Biron S, et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004; 135: 48–58PubMedCrossRefGoogle Scholar
  57. 57.
    Rand CS, Macgregor A, Hankins G. Gastric bypass surgery for obesity: weight loss, psychosocial outcome, and morbidity one and three years later. South Med J 1986 Dec; 79(12): 1511–4PubMedCrossRefGoogle Scholar
  58. 58.
    Kral JG, Sjostrom LV, Sullivan MB. Assessment of quality of life before and after surgery for severe obesity. Am J Clin Nutr 1992 Feb; 55(2 Suppl.): 611S–4SPubMedGoogle Scholar
  59. 59.
    Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Rouxen-Y gastric bypass for morbid obesity. Ann Surg 2000 Oct; 232(4): 515–29PubMedCrossRefGoogle Scholar
  60. 60.
    Powers PS. Conservative treatments for morbid obesity. In: Deitel M, editor. Surgery for the morbidly obese patient. Philadelphia (PA): Lea & Febiger, 1989: 27–37Google Scholar
  61. 61.
    Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg 2001; 234: 29–91CrossRefGoogle Scholar
  62. 62.
    Stamler R, Stamler J, Grimm R, et al. Nutritional therapy for high blood pressure: final report of a four-year randomized controlled trial: the Hypertension Control Program. JAMA 1987; 257: 1484–91PubMedCrossRefGoogle Scholar
  63. 63.
    Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Arch Intern Med 1990; 150: 153–62CrossRefGoogle Scholar
  64. 64.
    Elmer PJ, Grimm Jr R, Laing B, et al. Lifestyle intervention: results of the Treatment Of Mild Hypertension Study (TOMHS). Prev Med 1995; 24: 378–88PubMedCrossRefGoogle Scholar
  65. 65.
    Tuck ML, Sowers J, Dornfeld L, et al. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981; 304: 930–3PubMedCrossRefGoogle Scholar
  66. 66.
    Weinsier RL, James LD, Darnell BE, et al. Obesity-related hypertension: evaluation of the separate effects of energy restriction and weight reduction on hemodynamic and neuroendocrine status. Am J Med 1991; 90: 460–8PubMedGoogle Scholar
  67. 67.
    Davis BR, Blaufox MD, Oberman A, et al. Reduction in long-term antihypertensive medication requirements: effects of weight reduction by dietary intervention in overweight persons with mild hypertension. Arch Intern Med 1993; 153: 1773–82PubMedCrossRefGoogle Scholar
  68. 68.
    Stevens VJ, Corrigan SA, Obarzanek E, et al. Weight loss intervention in phase I of the trials of hypertension prevention: the TOHP Collaborative Research Group. Arch Intern Med 1993; 153: 849–58PubMedCrossRefGoogle Scholar
  69. 69.
    Kirschner MA, Schneider G, Ertel NH, et al. An eight-year experience with a very-low-calorie formula diet for control of major obesity. Int J Obes 1988; 12: 69–80PubMedGoogle Scholar
  70. 70.
    Sjostrom CD, Peltonen M, Wedel H, et al. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000; 36: 20–5PubMedCrossRefGoogle Scholar
  71. 71.
    Kannel WB, Gordon T. Obesity and cardiovascular disease. In: Burland W, Samuel PD, Yudkin J, editors. Obesity. London: Churchhill Davidson, 1974Google Scholar
  72. 72.
    Niebauer J, Hambrecht R, Velich T, et al. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation 1997 Oct 21; 96(8): 2534–41PubMedCrossRefGoogle Scholar
  73. 73.
    Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: the Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994 Mar; 89(3): 975–90PubMedCrossRefGoogle Scholar
  74. 74.
    Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990 Jul 21; 336(8708): 129–33PubMedCrossRefGoogle Scholar
  75. 75.
    United States National Commission on Diabetes. Report of the United States National Commission on Diabetes to the Congress of the United States, in publication number 76-1021. Bethesda (MD): US Department of Health, Education and Welfare, 1975Google Scholar
  76. 76.
    Bierman EL, Bagdade JD, Porte Jr D. Obesity and diabetes: the odd couple. Am J Clin Nutr 1968 Dec; 21(12): 1434–7PubMedGoogle Scholar
  77. 77.
    Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132(3): 501–13PubMedGoogle Scholar
  78. 78.
    Ohlson LO, Larsson B, Svardsudd K, et al. The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985; 34(10): 1055–8PubMedCrossRefGoogle Scholar
  79. 79.
    Wing RR, Marcus MD, Salata R, et al. Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med 1991 Jul; 151(7): 1334–40PubMedCrossRefGoogle Scholar
  80. 80.
    Fitz JD, Sperling EM, Fein HG. A hypocaloric high-protein diet as primary therapy for adults with obesity-related diabetes: effective long-term use in a community hospital. Diabetes Care 1983 Jul-Aug; 6(4): 328–33PubMedCrossRefGoogle Scholar
  81. 81.
    Torgerson JS, Hauptman J, Boldrin MN, et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27(1): 155–61PubMedCrossRefGoogle Scholar
  82. 82.
    Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med 1985 Dec; 103 (6 Pt 1): 983–8PubMedGoogle Scholar
  83. 83.
    Guilleminault C, Partinen M, Quera-Salva MA, et al. Determinants of daytime sleepiness and obstructive sleep apnea. Chest 1986; 94: 32–7CrossRefGoogle Scholar
  84. 84.
    Hackney JD, Crane MG, Collier CC, et al. Syndrome of extreme obesity and hypoventilation: studies of etiology. Ann Intern Med 1959; 51: 541–52PubMedGoogle Scholar
  85. 85.
    Sugerman H, Windsor A, Bessos M, et al. Abdominal pressure, sagittal abdominal diameter and obesity co-morbidity. J Intern Med 1997; 241: 71–9PubMedCrossRefGoogle Scholar
  86. 86.
    Suratt PM, McTier RF, Findley LJ, et al. Changes in breathing and the pharynx after weight loss in obstructive sleep apnea. Chest 1987 Oct; 92(4): 631–7PubMedCrossRefGoogle Scholar
  87. 87.
    Loube DI, Loube AA, Mitler MM. Weight loss for obstructive sleep apnea: the optimal therapy for obese patients. J Am Diet Assoc 1994 Nov; 94(11): 1291–5PubMedCrossRefGoogle Scholar
  88. 88.
    Smith PL, Gold AR, Meyers DA, et al. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985 Dec; 103 (6 Pt 1): 850–5PubMedGoogle Scholar
  89. 89.
    Sugerman H, Windsor A, Bessos M, et al. Effects of surgically induced weight loss on urinary bladder pressure, sagittal abdominal diameter and obesity comorbidity. Int J Obes Relat Metab Disord 1998 Mar; 22(3): 230–5PubMedCrossRefGoogle Scholar
  90. 90.
    Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol 1988; 45: 875–7PubMedCrossRefGoogle Scholar
  91. 91.
    Bloomfield GL, Blocher CR, Sugerman HJ. The relationship between elevated intra-abdominal, intrathoracic and raised intracranial pressure. Crit Care Med 1997; 25: 496–503PubMedCrossRefGoogle Scholar
  92. 92.
    Dent J, Dodds WJ, Hogan WJ, et al. Factors that influence induction of gastro-esophageal reflux in normal human subjects. Dig Dis Sci 1988; 33: 270–5PubMedCrossRefGoogle Scholar
  93. 93.
    Harrison SA, Kadakia S, Lang KA, et al. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 2002; 97: 2714–24PubMedGoogle Scholar
  94. 94.
    Maddox GL, Liederman V. Overweight as a social disability with medical implications. J Med Educ 1969 Mar; 44(3): 214–20PubMedGoogle Scholar
  95. 95.
    Rand CS, Macgregor AM. Morbidly obese patients’ perceptions of social discrimination before and after surgery for obesity. South Med J 1990 Dec; 83(12): 1390–5PubMedCrossRefGoogle Scholar
  96. 96.
    Schwartz MB, Chambliss HO, Brownell KD, et al. Weight bias among health professionals specializing in obesity. Obes Res 2003; 11: 1033–9PubMedCrossRefGoogle Scholar
  97. 97.
    Dixon JB, O’Brien PE. Changes in comorbidities and improvements in quality of life after Lap-Band® placement. Am J Surg 2002; 184: 51S–4SPubMedCrossRefGoogle Scholar
  98. 98.
    MacLean LD, Rhode BM, Sampalis J, et al. Results of the surgical treatment of obesity. Am J Surg 1993; 165: 155–62PubMedCrossRefGoogle Scholar
  99. 99.
    Sugerman HJ, Starkey JV, Birkenhauer RA. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty and their effects on sweets versus non-sweets eaters. Ann Surg 1987; 205: 613–24PubMedCrossRefGoogle Scholar
  100. 100.
    Hall JC, Watts JM, O’Brien PE, et al. Gastric surgery for morbid obesity: the Adelaide Study. Ann Surg 1990; 211: 419–27PubMedCrossRefGoogle Scholar
  101. 101.
    Howard L, Malone M, Michalek A, et al. Gastric bypass and vertical banded gastroplasty: a prospective randomized comparison and 5-year follow-up. Obes Surg 1995; 5: 55–60PubMedCrossRefGoogle Scholar
  102. 102.
    Yale CE. Gastric surgery for morbid obesity: complications and long-term weight control. Arch Surg 1989; 124: 941–6PubMedCrossRefGoogle Scholar
  103. 103.
    Brolin RL, Robertson LB, Kenler HA, et al. Weight loss and dietary intake after vertical banded gastroplasty and Rouxen-Y gastric bypass. Ann Surg 1994; 220: 782–90PubMedCrossRefGoogle Scholar
  104. 104.
    Capeila JF, Capeila RF. The weight reduction operation of choice: vertical banded gastroplasty or gastric bypass? Am J Surg 1996; 171: 74–9CrossRefGoogle Scholar
  105. 105.
    Buchwald H, Menchaca HJ, Menchaca YM, et al. Surgically induced weight loss: gastric bypass versus gastroplasty. Prob Gen Surg 2000; 17: 23–8Google Scholar
  106. 106.
    Sugerman HJ, Londrey GL, Kellum JM, et al. Weight loss with vertical banded gastroplasty and Rouxen-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg 1989; 157: 93–100PubMedCrossRefGoogle Scholar
  107. 107.
    DeMaria EJ, Sugerman HJ, Kellum JM, et al. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg 2002 May; 235(5): 640–5PubMedCrossRefGoogle Scholar
  108. 108.
    Higa KD, Ho T, Boone KB. Laparoscopic Rouxen-Y gastric bypass: technique and 3-year follow-up. J Laparoendosc Adv Surg Tech A 2001 Dec; 11(6): 377–82PubMedCrossRefGoogle Scholar
  109. 109.
    Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Rouxen-Y-500 patients: technique and results, with 5-60 month follow-up. Obes Surg 2000; 10: 233–9PubMedCrossRefGoogle Scholar
  110. 110.
    Fielding GA, Rhodes M, Nathanson LK. Laparoscopic gastric banding for morbid obesity: surgical outcome in 355 cases. Surg Endosc 1999; 13: 550–4PubMedCrossRefGoogle Scholar
  111. 111.
    Angrisani L, Alkilani M, Basso N, et al. Laparoscopic Italian experience with the Lap-Band®. Obes Surg 2001; 11: 307–10PubMedCrossRefGoogle Scholar
  112. 112.
    O’Brien PE, Dixon JB, Brown W. The laparoscopic adjustable gastric band (Lap-Band®): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg 2002; 12: 652–60PubMedCrossRefGoogle Scholar
  113. 113.
    Belachew M, Belva PH, Desaive C. Long-term results of laparoscopic adjustable gastric banding for the treatment of morbid obesity. Obes Surg 2002; 12: 564–89PubMedCrossRefGoogle Scholar
  114. 114.
    DeMaria EJ, Sugerman HJ, Meador JG, et al. High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. Ann Surg 2001; 233: 809–18PubMedCrossRefGoogle Scholar
  115. 115.
    Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22: 947–54PubMedCrossRefGoogle Scholar
  116. 116.
    Sugerman HJ, Kellum Jr JM, Reines HD, et al. Greater risk of incisional hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh. Am J Surg 1996 Jan; 171(1): 80–4PubMedCrossRefGoogle Scholar
  117. 117.
    Podnos YD, Jimenez JC, Wilson SE, et al. Complications after laparoscopic gastric bypass: a review of 3464 cases. Arch Surg 2003 Sep; 138(9): 957–61PubMedCrossRefGoogle Scholar
  118. 118.
    MacLean LD, Rhode BM, Nohr C, et al. Stomal ulcer after gastric bypass. J Am Coll Surg 1997 Jul; 185(1): 1–7PubMedCrossRefGoogle Scholar
  119. 119.
    Behrns KE, Smith CD, Sarr MG. Prospective evaluation of gastric acid secretion and cobalamin absorption following gastric bypass for clinically severe obesity. Dig Dis Sci 1994 Feb; 39(2): 315–20PubMedCrossRefGoogle Scholar
  120. 120.
    Sanyal AJ, Sugerman HJ, Kellum JM, et al. Stomal complications of gastric bypass: incidence and outcome of therapy. Am J Gastroenterol 1992 Sep; 87(9): 1165–9PubMedGoogle Scholar
  121. 121.
    Ido K, Suzuki T, Kimura K, et al. Lower-extremity venous stasis during laparoscopic cholecystectomy as assessed using color Doppler ultrasound. Surg Endosc 1995 Mar; 9(3): 310–3PubMedCrossRefGoogle Scholar
  122. 122.
    Wu EC, Barba CA. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obes Surg 2000 Feb; 10(1): 7–13PubMedCrossRefGoogle Scholar
  123. 123.
    Kothari SN, Sugerman HJ. Complications of bariatric surgery. Healthy Weight J 2003 Jul/Aug; 17(4): 52–5Google Scholar
  124. 124.
    Nguyen NT, Owings JT, Gosselin R, et al. Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Arch Surg 2001 Aug; 136(8): 909–16PubMedCrossRefGoogle Scholar
  125. 125.
    Elliot K. Nutritional considerations after bariatric surgery. Crit Care Nurs Q 2003 Apr-Jun; 26(2): 133–8PubMedGoogle Scholar
  126. 126.
    Oczkowski WJ, Kertesz A. Wernicke’s encephalopathy after gastroplasty for morbid obesity. Neurology 1985; 35: 99–101PubMedCrossRefGoogle Scholar
  127. 127.
    Somer H, Bergstrom L, Mustajoki P, et al. Morbid obesity, gastric plication and a severe neurological deficit. Acta Med Scand 1985; 217: 575–6PubMedCrossRefGoogle Scholar
  128. 128.
    Chaves LC, Faintuch J, Kahwage S, et al. A cluster of polyneuropathy and Wernicke-Korsakoff syndrome in a bariatric unit. Obes Surg 2002 Jun; 12(3): 328–34PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • Michael D. Lara
    • 1
  • Shanu N. Kothari
    • 1
  • Harvey J. Sugerman
    • 2
  1. 1.Department of General and Vascular SurgeryGundersen Lutheran Medical CenterLaCrosseUSA
  2. 2.Division of General/Trauma Surgery, Medical College of VirginiaVirginia Commonwealth UniversityRichmondUSA

Personalised recommendations